Salivary Alpha-Synuclein to Differentiate Parkinson’s Disease from Drug Induced Parkinsonism and Controls Using ELISA

Article de revue

Cécile Aerts, Christophe Hirtz, Victoria Gonzalez, Teodora Parvu, Marie De Verdal, Valérie Cochen de Cock, Estelle Moulis Estelle Moulis, Pascale Fabbro-Peray, Sylvain Lehmann, Sandrine Alonso, …

Journal of Neurology and Translational Neuroscience, Vol.8(1), pp.1-4

07/12/2024

Résumé

Background: Alpha-synuclein is a promising biomarker for Parkinson’s disease (PD).

1 Consultations de la notice

Titre: Salivary Alpha-Synuclein to Differentiate Parkinson’s Disease from Drug Induced Parkinsonism and Controls Using ELISA
Créateurs - sans rôle: Cécile Aerts
Christophe Hirtz
Victoria Gonzalez
Teodora Parvu
Marie De Verdal
Valérie Cochen de Cock
Estelle Moulis Estelle Moulis
Pascale Fabbro-Peray
Sylvain Lehmann
Sandrine Alonso
Giovanni Castelnovo
LBPC-PPC, University of Montpellier, INM INSERM, IRMB CHU of Montpellier, Montpellier, France
Détails de publication: Journal of Neurology and Translational Neuroscience, Vol.8(1), pp.1-4
Nombre de pages: 4
Identifiants: 99136794509311
Unité académique: EuroMov Digital Health in Motion - EuroMov DHM
Langue: English
Type de ressource: Journal article